Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Microbot Medical Inc
MBOT | US
2.01
USD0.03
1.52%
MBOT | US
Loading StockChartView...
About Microbot Medical Inc
Sector
Healthcare
Industry
Medical Instruments & Supplies
Earnings date
30/06/2024
As of date
02/06/2026
Close
2.01
Open
1.99
High
2.03
Low
1.95
Microbot Medical Inc. a pre-clinical medical device company engages in the research design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY a disposable robotic system for use in endovascular interventional procedures such as cardiovascular peripheral and neurovascular; NovaCross an intraluminal revascularization device; ViRob an autonomous crawling micro-robot that cam crawl in various natural spaces within the human body including blood vessels the digestive tract and the respiratory system as well as artificial spaces such as shunts catheters ports etc.; TipCAT a disposable self-propelled locomotive device for tubular anatomies; and One & Done platform. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham Massachusetts.
View LessMBOT | US
Risk
84.1
Sharpe
-0.31
Luna's Score
46/100
Recommendation
Hold
Luna says (MBOT | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
87.9%1 month
84.1%3 months
70.3%6 months
75.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.63
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
-0.89
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-9.41M
MarketCap
33.17M
MarketCap(USD)
33.17M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-134.46
Short ratio
3.10
Short perc.
1.98
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.52
Range1M
0.59
Range3M
1.20
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.61
Price X volume
2.52M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.89 | 4.19 | Cheaper |
| Ent. to Revenue | - | 8.10 | - |
| PE Ratio | - | 47.18 | - |
| Price to Book | 2.63 | 5.71 | Cheaper |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 70.28 | 56.96 | Riskier |
| Debt to Equity | 0.02 | 0.92 | Cheaper |
| Debt to Assets | 0.02 | 0.27 | Cheaper |
| Market Cap | 33.17M | 10.37B | Emerging |
